We first determined SLC6A3 expression in ACHN, A498, Caki-1, Caki-2 and 769-P RCC cell lines; based on the SLC6A3 expression levels in the cell lines, we excluded ACHN, Caki-2 and 769-P from further analyses. The gene discussed is SLC6A3; the disease is renal cell carcinoma.